Myoblast determination protein 1 (MYOD) is a transcription factor that plays an important role in myogenic cell determination and differentiation.
9,10 Both the PITX2 and PAX7 myogenic precursor cells activate MYOD, as MYOD is one of the first molecular steps toward myogenic differentiation. MYOD-positive cells are common during muscle development but gradually decrease in number in normal limb skeletal muscle unless injured or diseased.
11 However, MYOD-positive cells are easily identified in the adult extraocular muscles,
1–4 including human extraocular muscles from elderly individuals.
3 When
MyoD−/− mice were developed, interestingly there was no overt muscle pathology in the limb skeletal muscles that were studied.
12 Further study showed that mice with a deletion of MYOD in limb skeletal muscles had a differentiation-defective phenotype in vitro,
13,14 as well as a regeneration deficient phenotype in vivo.
15,16 The effect of loss of MYOD expression has not been examined in the extraocular muscles. In light of the fact that the extraocular muscles have continuous and life-long myonuclear addition and turnover,
4,5 we hypothesized that loss of MYOD in skeletal muscle would result in abnormal extraocular muscle structure and function compared with normal. One way to analyze extraocular muscle function and integrity is by measuring the optokinetic nystagmus (OKN) response, which works very effectively in humans, as well as in mice, to determine normal and abnormal eye movements.
17,18 We examined the OKN response in the
MyoD−/− mice to assess if their eye muscles were functioning normally compared with wild-type littermate controls. Additionally, we determined myofiber cross-sectional areas and total myofiber number in the extraocular muscles from the
MyoD−/− mice compared with their littermate controls at 3, 6, and 12 months of age to determine if the absence of MYOD expression would alter these characteristics in a muscle with such a high rate of myofiber remodeling.